Years Isolated from Italian Students Aged 14 to 22 Neisseria meningitidis Carrier Strains Molecular and Serological Diversity of

Published Ahead of Print 19 March 2014. 10.1128/JCM.03584-13. 2014, 52(6):1901. DOI: J. Clin. Microbiol. Panatto Marzia Monica Giuliani, Mariagrazia Pizza and Donatella Simmini, Giueseppe Boccadifuoco, Brunella Brunelli, Bambini, Monica Moschioni, Sara Comandi, Isabella Icardi, Emanuela Rizzitelli, Gabriella De Angelis, Stefania Filippo Ansaldi, Paola Canepa, Andrea Orsi, Giancarlo Roberto Gasparini, Maurizio Comanducci, Daniela Amicizia, Years Isolated from Italian Students Aged 14 to 22 Neisseria meningitidis Carrier Strains Molecular and Serological Diversity of

[1]  M. Snape,et al.  A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn? , 2013, Expert review of vaccines.

[2]  C. Donati,et al.  Conservation of Meningococcal Antigens in the Genus Neisseria , 2013, mBio.

[3]  R. Rappuoli,et al.  Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. , 2013, The Lancet. Infectious diseases.

[4]  L. Rubin,et al.  Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale , 2013, MMWR. Morbidity and mortality weekly report.

[5]  John L. Perez,et al.  Potential impact of the bivalent rLP2086 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease , 2012, Human vaccines & immunotherapeutics.

[6]  R. Rappuoli,et al.  Interlaboratory Standardization of the Sandwich Enzyme-Linked Immunosorbent Assay Designed for MATS, a Rapid, Reproducible Method for Estimating the Strain Coverage of Investigational Vaccines , 2012, Clinical and Vaccine Immunology.

[7]  R. Gasparini,et al.  Neisseria meningitidis, pathogenetic mechanisms to overcome the human immune defences. , 2012, Journal of preventive medicine and hygiene.

[8]  L. Harrison,et al.  The changing and dynamic epidemiology of meningococcal disease. , 2012, Vaccine.

[9]  P. Dull,et al.  Meningococcal vaccine development--from glycoconjugates against MenACWY to proteins against MenB--potential for broad protection against meningococcal disease. , 2012, Vaccine.

[10]  S. Meri,et al.  Capsule null locus meningococci: typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine. , 2012, Vaccine.

[11]  C. Hogea,et al.  Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region , 2011, Expert review of anti-infective therapy.

[12]  L. Harrison,et al.  Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates. , 2011, Vaccine.

[13]  D. Toneatto,et al.  The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans , 2011, Human vaccines.

[14]  J. Findlow,et al.  Molecular Targets in Meningococci: Efficient Routine Characterization and Optimal Outbreak Investigation in Conjunction with Routine Surveillance of the Meningococcal Group B Vaccine Candidate, fHBP , 2010, Clinical and Vaccine Immunology.

[15]  C. Napoli,et al.  Young-adult carriers of Neisseria meningitidis in Puglia (Italy): Will the pattern of circulating meningococci change following the introduction of meningococcal serogroup C conjugate vaccines? , 2010, Human vaccines.

[16]  M. May,et al.  Meningococcal carriage by age: a systematic review and meta-analysis. , 2010, The Lancet. Infectious diseases.

[17]  M. Pizza,et al.  Characterization of fHbp, nhba (gna2132), nadA, porA, and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal Vaccine , 2010, Clinical and Vaccine Immunology.

[18]  R. Rappuoli,et al.  Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans , 2010, Proceedings of the National Academy of Sciences.

[19]  M. Virji,et al.  Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease , 2010, Clinical science.

[20]  P. Mastrantonio,et al.  Neisseria meningitidis Serogroup X Sequence Type 2888, Italy , 2010, Emerging infectious diseases.

[21]  M. Pizza,et al.  Characterization of fHbp, nhba (gna2132), nadA, porA, Sequence Type (ST), and Genomic Presence of IS1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales , 2009, Journal of Clinical Microbiology.

[22]  M. Maiden,et al.  Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs , 2009, Expert review of vaccines.

[23]  Lee H Harrison,et al.  Global epidemiology of meningococcal disease. , 2009, Vaccine.

[24]  P. Manfredi,et al.  On the relationship between meningococcal transmission dynamics and disease: remarks on humoral immunity. , 2009, Vaccine.

[25]  R. Rappuoli,et al.  Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus. , 2009, Vaccine.

[26]  R. Rappuoli,et al.  Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease. , 2009, Vaccine.

[27]  R. Reintjes,et al.  Longitudinal study of meningococcal carrier rates in teenagers. , 2008, International journal of hygiene and environmental health.

[28]  D. Crook,et al.  Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. , 2008, The Journal of infectious diseases.

[29]  S. Chanteau,et al.  Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  K. Jolley,et al.  A surveillance network for meningococcal disease in Europe. , 2007, FEMS microbiology reviews.

[31]  D. Caugant,et al.  Lessons from meningococcal carriage studies. , 2007, FEMS microbiology reviews.

[32]  D. Caugant,et al.  Pharyngeal carriage of Neisseria meningitidis in 2-19-year-old individuals in Uganda. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[33]  N. Andrews,et al.  Social Behavior and Meningococcal Carriage in British Teenagers , 2006, Emerging infectious diseases.

[34]  L. McCallum,et al.  The VR2 Epitope on the PorA P1.7-2,4 Protein Is the Major Target for the Immune Response Elicited by the Strain-Specific Group B Meningococcal Vaccine MeNZB , 2006, Clinical and Vaccine Immunology.

[35]  Daniel J. Wilson,et al.  Distribution of Serogroups and Genotypes among Disease-Associated and Carried Isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway , 2004, Journal of Clinical Microbiology.

[36]  Edward C. Holmes,et al.  Distribution of Surface Protein Variants among Hyperinvasive Meningococci: Implications for Vaccine Design , 2004, Infection and Immunity.

[37]  D. Caugant,et al.  Neisseria meningitidis: an overview of the carriage state. , 2004, Journal of medical microbiology.

[38]  R. Rappuoli,et al.  NadA Diversity and Carriage in Neisseria meningitidis , 2004, Infection and Immunity.

[39]  M. Cafferkey,et al.  PCR-Based Assay for Detection of Neisseria meningitidis Capsular Serogroups 29E, X, and Z , 2004, Journal of Clinical Microbiology.

[40]  M. Unemo,et al.  Analysis of PorA variable region 3 in meningococci: implications for vaccine policy? , 2003, Vaccine.

[41]  S. Clarke,et al.  Identification of Neisseria meningitidis Serogroups Y and W135 by siaD Nucleotide Sequence Analysis , 2003, Journal of Clinical Microbiology.

[42]  D. Stephens,et al.  Genetic basis for nongroupable Neisseria meningitidis. , 2003, The Journal of infectious diseases.

[43]  Jeannette Adu-Bobie,et al.  Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870 , 2003, The Journal of experimental medicine.

[44]  T. Popović,et al.  Sequence Diversity of Neisseria meningitidis 16S rRNA Genes and Use of 16S rRNA Gene Sequencing as a Molecular Subtyping Tool , 2002, Journal of Clinical Microbiology.

[45]  Anne Perrocheau,et al.  Outbreak of Serogroup W135 Meningococcal Disease after the Hajj Pilgrimage, Europe, 2000 , 2002, Emerging infectious diseases.

[46]  R. Rappuoli,et al.  NadA, a Novel Vaccine Candidate of Neisseria meningitidis , 2002, The Journal of experimental medicine.

[47]  M. Maiden,et al.  Many carried meningococci lack the genes required for capsule synthesis and transport. , 2002, Microbiology.

[48]  M. Unemo,et al.  Genosubtyping by sequencing group A, B and C meningococci; a tool for epidemiological studies of epidemics, clusters and sporadic cases , 2000, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[49]  M. Taha,et al.  Simultaneous Approach for Nonculture PCR-Based Identification and Serogroup Prediction of Neisseria meningitidis , 2000, Journal of Clinical Microbiology.

[50]  M. Achtman,et al.  Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  S. Hammerschmidt,et al.  Capsule phase variation in Neisseria meningitidis serogroup B by slipped‐strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease , 1996, Molecular microbiology.

[52]  T. Rønne,et al.  Comparative studies on pharyngeal carriage of Neisseria meningitidis during a localized outbreak of serogroup C meningococcal disease. , 1993, Scandinavian journal of infectious diseases.

[53]  M. Leinonen,et al.  ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS Implications for Vaccine Development and Pathogenesis , 1983, The Lancet.

[54]  J. D. Abbott,et al.  The meningococcal carrier-rate. , 1973, Lancet.

[55]  M. Artenstein,et al.  Human immunity to the meningococcus. II. Development of natural immunity. , 1969 .

[56]  M. Artenstein,et al.  HUMAN IMMUNITY TO THE MENINGOCOCCUS I. THE ROLE OF HUMORAL ANTIBODIES , 1969 .